Post by ASAPbio Fellow Aleksandra Petelski The usage of preprints in the clinical world is drastically increasing, especially during the current COVID-19 pandemic. In this rapidly developing situation, medRxiv already received over 8,000 preprints (and counting) involving COVID-19 at the current time of writing [1]. The use of preprints as a means for science dissemination…
Blog post by ASAPbio Fellow Suraj Kannan The recent emergence of preprints in clinical research (most prominently through medRxiv) has raised a number of questions about their potential for benefit/harm. Preprints and preprint servers have existed in various basic and hard science disciplines for the past several decades, and have improved speed of dissemination and…
“We have to be the change we want to see… increasing preprint engagement requires a system-wide change in how we value publications and commencing a dialogue that we can all be a part of.” As part of Clinician’s Corner we would like practicing clinicians to share their opinions and experiences on preprint usage within the…
A series aimed at opening the dialogue surrounding preprint usage in the clinical community. Run by the ASAPbio Fellows Vanessa Bortoluzzi, Kirsty Ferguson, Suraj Kannan and Aleksandra Petelski. Today, scientific discovery moves at a faster pace than even a decade ago [1]. However, the publishing process required by journals does not seem able to keep…